Tyrosine Kinase Inhibitor for Ph+ CML
Created 3 weeks ago by anniepery

Bosutinib is used for the treatment of adult patients with chronic, accelerated, or blast phase Ph+ chronic myelogenous leukemia with resistance or intolerance to prior therapy. The bosutinib cost may range from 8,900 INR to 11,000 INR for a supply of 30 Tablets. The recommended dose of bosutinib is 500 mg, which should be administered orally once daily with food at about the same time every day. Women of reproductive age should avoid becoming pregnant while taking treatment with bosutinib.